NO20030946L - Medisinske sammensetninger - Google Patents

Medisinske sammensetninger

Info

Publication number
NO20030946L
NO20030946L NO20030946A NO20030946A NO20030946L NO 20030946 L NO20030946 L NO 20030946L NO 20030946 A NO20030946 A NO 20030946A NO 20030946 A NO20030946 A NO 20030946A NO 20030946 L NO20030946 L NO 20030946L
Authority
NO
Norway
Prior art keywords
medical compositions
medical
compositions
Prior art date
Application number
NO20030946A
Other languages
English (en)
Other versions
NO20030946D0 (no
Inventor
Takafumi Kohama
Toshimori Inaba
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20030946D0 publication Critical patent/NO20030946D0/no
Publication of NO20030946L publication Critical patent/NO20030946L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO20030946A 2000-09-01 2003-02-28 Medisinske sammensetninger NO20030946L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000265082 2000-09-01
PCT/JP2001/007438 WO2002020009A1 (fr) 2000-09-01 2001-08-29 Compositions medicales

Publications (2)

Publication Number Publication Date
NO20030946D0 NO20030946D0 (no) 2003-02-28
NO20030946L true NO20030946L (no) 2003-04-08

Family

ID=18752403

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030946A NO20030946L (no) 2000-09-01 2003-02-28 Medisinske sammensetninger

Country Status (17)

Country Link
EP (1) EP1314423A4 (no)
KR (1) KR20030029871A (no)
CN (1) CN1473042A (no)
AU (2) AU8254101A (no)
BR (1) BR0113523A (no)
CA (1) CA2420951A1 (no)
CZ (1) CZ2003593A3 (no)
HU (1) HUP0301728A3 (no)
IL (1) IL154414A0 (no)
MX (1) MXPA03001857A (no)
NO (1) NO20030946L (no)
NZ (1) NZ524406A (no)
PL (1) PL362244A1 (no)
RU (1) RU2246302C2 (no)
SK (1) SK2552003A3 (no)
WO (1) WO2002020009A1 (no)
ZA (1) ZA200301543B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030029871A (ko) * 2000-09-01 2003-04-16 상꾜 가부시키가이샤 의약 조성물
CA2535920C (en) 2003-08-29 2009-06-23 Kowa Co., Ltd. Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3720395B2 (ja) * 1994-09-20 2005-11-24 京都薬品工業株式会社 新規ヘテロ環誘導体、その製造方法およびその医薬用途
ATE210116T1 (de) * 1995-10-05 2001-12-15 Kyoto Pharma Ind Neue heterozyklische derivate und ihre medizinische anwendung
PL186714B1 (pl) * 1995-11-02 2004-02-27 Warner Lambert Co Kompozycja farmaceutyczna do regulowania stężenialipidów do ssaka
SK65499A3 (en) * 1996-11-27 2001-05-10 Pfizer Apo b-secretion/mtp inhibitory amides
JP3333777B2 (ja) * 1997-10-28 2002-10-15 コリア インスティテュート オブ サイエンス アンド テクノロジー アシルｃｏａ−コレステロール−ｏ−アシルトランスフェラーゼ抑制剤、動脈壁上でのマクロファージ−脂質複合体蓄積の抑制剤および肝疾患予防または治療剤としての柑橘類果皮抽出物
OA11584A (en) * 1998-07-21 2004-07-20 Warner Lambert Co Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions.
AU7717500A (en) * 1999-09-30 2001-04-30 Merck & Co., Inc. Anti-hypercholesterolemic drug combination
KR20030029871A (ko) * 2000-09-01 2003-04-16 상꾜 가부시키가이샤 의약 조성물

Also Published As

Publication number Publication date
HUP0301728A2 (hu) 2003-08-28
RU2246302C2 (ru) 2005-02-20
HUP0301728A3 (en) 2004-05-28
WO2002020009A1 (fr) 2002-03-14
SK2552003A3 (en) 2003-08-05
NO20030946D0 (no) 2003-02-28
EP1314423A1 (en) 2003-05-28
EP1314423A4 (en) 2004-05-19
CN1473042A (zh) 2004-02-04
IL154414A0 (en) 2003-09-17
ZA200301543B (en) 2004-06-09
PL362244A1 (en) 2004-10-18
AU2001282541B2 (en) 2004-06-24
MXPA03001857A (es) 2003-06-04
AU8254101A (en) 2002-03-22
CZ2003593A3 (cs) 2003-05-14
CA2420951A1 (en) 2003-02-28
NZ524406A (en) 2004-06-25
KR20030029871A (ko) 2003-04-16
BR0113523A (pt) 2004-06-29

Similar Documents

Publication Publication Date Title
ATE303787T1 (de) Schergelzusammensetzungen
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
DK1199054T3 (da) Væskefrakturhånddel
DK1317177T3 (da) Desinficerende formuleringer
IS2932B (is) Fúlvestrant samsetning
ITMI20010748A0 (it) Composizioni farmaceutiche
NO20026175L (no) Vaksinesammensetning
DK1524266T3 (da) Farmaceutisk sammensætning
AR028197A1 (es) Composiciones antitranspirantes
FI20010780A0 (fi) Parannetut koostumukset
DE60125806D1 (de) Chirurgische spüleinrichtung
DE60106275T8 (de) Dermatologische zusammensetzung
AR023440A1 (es) Composiciones antitranspirantes
DE60100567D1 (de) Antimikrobielle zusammensetzungen
DE60137637D1 (de) Magnetorheologische fettzusammensetzung
AR028087A1 (es) Composiciones cosmeticas
ATE257691T1 (de) Schweisshemmende zusammensetzungen
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
NO20026123L (no) Farmasöytiske sammensetninger
DE60139896D1 (de) Ldenden zusammensetzungen
NO20031095D0 (no) Farmasöytiske sammensetninger
DE60116858D1 (de) Zusammensetzung
DE60142401D1 (de) Verbindungsverfahren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application